Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index; 16 of the 27 sources its claims cite were checked for support.

Levothyroxine Absorption Test With the Daily Levothyroxine Dose in Patients With “Refractory Hypothyroidism”

Open access
Caron, Philippe, Tudor, Charlotte, Grunenwald, Solange · 2025 · Journal of the Endocrine Society

Abstract

Hypothyroidism is a frequent disease, and oral levothyroxine is the mainstay of its treatment. However, more than 15% of levothyroxine-treated patients fail to achieve the recommended serum TSH level, and “refractory hypothyroidism” is due to either malabsorption, increased metabolism of thyroxine, or nonadherence to treatment. A levothyroxine absorption test must be used to differentiate true malabsorption from nonadherence or pseudo-malabsorption. We analyzed 166 levothyroxine absorption tests in 143 hypothyroid patients (109 women, mean age 43 ± 1 years) treated with oral levothyroxine. Despite a daily dose of 3.26 ± 0.09 µg/kg/day, mean serum TSH concentration was 25.7 ± 3.7 mU/L. “Refractory hypothyroidism” was in the context of gastritis (24%), Helicobacter pylori infection (18%), drug interference with levothyroxine absorption (15.6%), nonadherence to treatment (10%), celiac disease (2.5%), or bariatric surgery (1.2%). After an overnight fast, patients orally took their daily dose of levothyroxine (220 ± 6 µg), and blood samples were drawn before levothyroxine intake and every 2 hours for 24 hours. After levothyroxine intake, the mean total (basal = 7.64 ± 0.26 µg/dL, peak 9.41 ± 0.28 µg/dL), and free (basal = 12.58 ± 0.42 pg/mL, peak 15.77 ± 0.51 pg/mL) T4 levels increased (P < .001), total and free T4 peaks were observed at 4.2 ± 0.23 and 4.30 ± 9.27 hours, respectively. Levothyroxine absorption tests were well tolerated. In conclusion, in most patients with “refractory hypothyroidism,” this clinical study revealed that the levothyroxine absorption test can be achieved via the absorption of the daily dosage of levothyroxine, and the evaluation of total or free T4 concentrations over 4- or 6-hour follow-up. The test is well tolerated without cardiovascular adverse events.

Overview

CoChat Summary

TL;DR

In 143 patients with “refractory hypothyroidism,” a levothyroxine absorption test using the patient’s daily levothyroxine dose produced measurable total and free T4 increases and was well tolerated. The authors conclude the test can be performed with the daily dose and total or free T4 sampling over 4 to 6 hours.

Key findings

  • Across 166 tests in 143 patients (109 women; mean age 43 ± 1 years), mean levothyroxine dose was 220 ± 6 µg/day or 3.26 ± 0.09 µg/kg/day, while mean serum TSH was 25.7 ± 3.7 mU/L in the abstract.
  • After daily-dose levothyroxine, total T4 rose from 7.64 ± 0.26 to 9.41 ± 0.28 µg/dL and free T4 from 12.58 ± 0.42 to 15.77 ± 0.51 pg/mL (both P < .001); peaks occurred at 4.2 ± 0.2 and 4.3 ± 0.2 hours, respectively.
  • Mean TSH did not change at 24 hours (25.1 ± 3.3 to 25.5 ± 3.4 mU/L, ns). No adverse events were reported during the 24-hour follow-up.
  • Percentage absorption was lower in autoimmune/chronic gastritis than in pseudo-malabsorption (60 ± 9% vs 116 ± 19%, P < .01), with lower TT4 and FT4 increases; decreases were also observed with H. pylori infection or proton pump inhibitor treatment.

Methods

  • Retrospective analysis of levothyroxine absorption tests performed between January 2006 and December 2023 in patients with TSH above the reference range despite relatively large levothyroxine doses.
  • After an overnight fast, patients received their daily levothyroxine dose under supervision; blood was drawn before intake and every 2 hours for 24 hours. Total T4 and free T4 were measured in all samples, and TSH at baseline and in the last sample.
  • Percentage levothyroxine absorption was calculated using peak minus baseline TT4, volume of distribution = 0.442 × BMI, and administered dose; <60% indicated malabsorption. Assays were ADVIA Centaur (2006-2014) and Cobas 8000 (2015-2023).

Limitations

  • The authors state the study was retrospective and therefore had inherent bias.
  • The authors state they did not determine sensitivity and specificity of cutoff total and free T4 values to differentiate malabsorption syndrome from noncompliance.
  • The text also notes that using total T4 concentration or percentage absorption may be a limitation because total T4 is influenced by more factors than free T4; assay changes over the study period are evident from the methods and may affect comparability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/jendso/bvaf017

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Total (TT4) and free (FT4) thyroxine concentrations after absorption of daily levothyroxine dose in 143 patients with “refractory hypothyroidism.” Normal range TT4: 4.6-11 µg/dL, FT4: 9.3-17 pg/mL.
Figure 1. Total (TT4) and free (FT4) thyroxine concentrations after absorption of daily levothyroxine dose in 143 patients with “refractory hypothyroidism.” Normal range TT4: 4.6-11 µg/dL, FT4: 9.3-17 pg/mL.CC BY · PubMed Central

Verification

Claims the paper makes

9 Valid · 0 Not valid · 3 Not checked · 28 Own results and interpretations

16 more claims

Create a free account to see all 40 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 8
  • It may state two separate claims as one. 11
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 25 references

Research works printed but not linked: 2

  1. Soares, 2016, Rapid levothyroxine (lt4) absorption test for diagnosis of LT4 pseudomalabsorption: case report and proposal of a cutoff point, J Endocrinol Diabetes Obes, 4, 1083
  2. Greenstadt, 1981, 1981 development of a non-isotopic method for determination of oral T4 absorption, Clin Res, 29, A83

Cited by

See all 8

Metadata

Authors
Caron, P., Tudor, C., & Grunenwald, S.
Affiliations
Hôpital Larrey (FR)
Corresponding author
Caron, Philippe
Venue
Journal of the Endocrine Society
Published
2025-03-03
Volume
9
Issue
4
Pages
bvaf017-bvaf017
ISSN
2472-1972 (ISSN-L)
OpenAlex
W4408146948
Cited by
8
References
25
Citations by year
2026: 7 · 2025: 1
FWCI
4.39
Type
journal article
Language
en
Open access
Locations
  • Journal of the Endocrine Society (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
refractory hypothyroidism, thyroxine metabolism, treatment non-adherence, free thyroxine, total thyroxine, serum TSH, gastritis, Helicobacter pylori infection, celiac disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Levothyroxine Absorption Test With the Daily Levothyroxine Dose in Patients With “Refractory Hypothyroidism”. https://app.cochat.ai/papers/10.1210/jendso/bvaf017
The paper
Caron, P., Tudor, C., & Grunenwald, S. (2025). Levothyroxine Absorption Test With the Daily Levothyroxine Dose in Patients With “Refractory Hypothyroidism”. Journal of the Endocrine Society. https://doi.org/10.1210/jendso/bvaf017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.